Recombinant Monoclonal Human anti-Human CD22 Antibody (clone hL22 (Epratuzumab), CD22) LS-C777525
Artikelnummer:
LS-C777525-0.2
Produktübersicht
Artikelname:
Recombinant Monoclonal Human anti-Human CD22 Antibody (clone hL22 (Epratuzumab), CD22) LS-C777525
Artikelnummer:
LS-C777525-0.2
Hersteller Artikelnummer:
LS-C777525-0.2
Alternativnummer:
LS-C777525-0.2
Hersteller:
LifeSpan Biosciences
Wirt:
Human
Kategorie:
Antikörper
Applikation:
Blocking, FC, IP
Spezies Reaktivität:
Human, Monkey
Immunogen:
This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10% of the molecule, with the remainder being human framework sequences, which greatly reduces
Konjugation:
Unconjugated
Alternative Synonym:
CD22, CD22 molecule, CD22 antigen, SIGLEC2, SIGLEC-2, T-cell surface antigen Leu-14, B-cell receptor CD22, BL-CAM
Produktbeschreibung
This CD22 antibody is an unconjugated Human/Human chimeric recombinant monoclonal antibody. Validated for Block, Flo, and IP.
Produkteigenschaften
Klonalität:
Monoclonal
Konzentration:
1 mg/ml
Klon-Bezeichnung:
[hL22 Epratuzumab]
NCBI:
933
Puffer:
PBS, 0.02% ProClin(TM) 300.
Reinheit:
Protein A purified
Formulierung:
PBS, 0.02% ProClin(TM) 300.
Anwendungsbeschreibung
Application Verdünnung:
Block, Flo, IP
Anwendungsbeschreibung:
Applications should be user optimized.
